ALCOLADO RELAMPAGO topical liniment recalled for manufacturing process violations
Ecometics, Inc. is recalling ALCOLADO RELAMPAGO (menthol and camphor) topical liniment nationwide due to manufacturing process deviations. Products were not manufactured under current good manufacturing practices.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall based on manufacturing practice deviations. No illnesses, injuries, or deaths have been reported in the source material. The recall is precautionary in nature, triggered by CGMP violations rather than documented safety incidents.
Plain-English summary
Ecometics, Inc. is recalling ALCOLADO RELAMPAGO, a menthol and camphor topical liniment, due to manufacturing process deviations. The product was distributed nationwide in 7 fluid ounce (207 ml) and 16 fluid ounce (472 ml) bottle sizes by The Larkspur Group, Inc., Norwalk, Connecticut.
The products were not manufactured under current good manufacturing practices (CGMP). Current good manufacturing practices are FDA requirements that ensure products are produced with appropriate quality controls and procedures.
The recall includes multiple lot codes with expiration dates from October 2023 through May 2024. Consumers who have purchased this product should discontinue use immediately.
The recalled product
- Product
- ALCOLADO RELAMPAGO (Menthol and Camphor), 1% and 1.5% respectively, packaged in a 7 FLUID OZ (207 ml) bottles, UPC 7 18864 20102 9 and b) 16 FLUID OZ (472 ml) bottles, UPC 7 18864, 20110 4, Distributed by: The Larkspur Group, Inc., Norwalk, CT 06854.
- Manufacturer
- Ecometics, Inc.
- Category
- Drug — Topical Liniment
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- a) 0E280A
- exp 10/23
- 0E318A
- exp 11/23
- 1E109A
- exp 3/24
- 1E141A
- exp 5/24
- b) 0E280A
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 7 recalled by Ecometics, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · Ecometics, Inc.
See all →- HighFDA Recalls AstrinGyn Surgical Hemostatic Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-08-30
- ModerateBlis-To-Sol Tolnaftate Liquid Recalled for Manufacturing Practice Deviations
FDA (Drugs) · 2023-08-30
- HighLugol's Strong Iodine Solution Recalled Due to Manufacturing Quality Deviations
FDA (Drugs) · 2023-08-30
- ModerateUnguentine Ointment Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-08-30
- HighYager's Liniment Recalled for Manufacturing Practice Violations
FDA (Drugs) · 2023-08-30
Same hazard · manufacturing deviation
See all →- HighBaxter Recalls Vancomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateSynjardy XR Tablets Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2026-07-08
- ModerateDuloxetine delayed-release capsules recalled for N-nitroso impurity contamination
FDA (Drugs) · 2026-05-13
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
Similar recalls
- ModerateDrug Recall: Alcolado Relampago Topical for Manufacturing Practice Deviations
FDA (Drugs) · 2023-03-15
- ModerateFDA Recalls Nose Better Gel Due to Manufacturing Process Deviations
FDA (Drugs) · 2023-03-15
- ModerateMedicated Balm Recalled for Manufacturing Process Deviations
FDA (Drugs) · 2023-03-15
- ModeratePharma-Natural Recalls Lid O Creme Due to Manufacturing Violations
FDA (Drugs) · 2019-07-31
- ModerateAntifungal Drug Recalled for Manufacturing Process Deviations
FDA (Drugs) · 2025-05-28
- HighKetorolac Tromethamine ophthalmic solution recalled due to manufacturing deviations
FDA (Drugs) · 2023-01-25